SUCCESSFUL USE OF VON WILLEBRAND FACTOR WITH A LOW FVIII CONTENT FOR THE SECONDARY LONG-TERM PROPHYLAXIS OF VON WILLEBRAND DISEASE TYPE 3-OUR 7 YEARS OF EXPERIENCE

被引：0
|
作者：
Simurda, T. [1 ]
Skornova, I. [1 ]
Drotarova, M. [1 ]
Lisa, L. [1 ]
Brunclikova, M. [1 ]
Stasko, J. [1 ]
机构：
[1] Comenius Univ, Jessenius Fac Med Martin, Dept Hematol & Transfusiol, Nat Ctr Hemostasis & Thrombosis,Univ Hosp Martin, Martin, Slovakia
来源：
HAEMOPHILIA | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO231
引用
收藏
页码：152 / 152
页数：1
相关论文
共 50 条
  • [1] Successful Use of a Highly Purified Plasma von Willebrand Factor Concentrate Containing Little FVIII for the Long-Term Prophylaxis of Severe (Type 3) von Willebrand's Disease
    Simurda, Tomas
    Dobrotova, Miroslava
    Skornova, Ingrid
    Sokol, Juraj
    Kubisz, Peter
    Stasko, Jan
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (06): : 639 - 641
  • [2] Outcomes of long-term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review
    El Alayli, Abdallah
    Petersen, Romina Brignardello
    Husainat, Nedaa M.
    Kalot, Mohamad A.
    Aljabiri, Yazan
    Turkmani, Hani
    Britt, Alec
    El-Khechen, Hussein
    Shahid, Shaneela
    Roller, John
    Motaghi, Shahrzad
    Mansour, Razan
    Tosetto, Alberto
    Abdul-Kadir, Rezan
    Laffan, Michael
    Weyand, Angela
    Leebeek, Frank W. G.
    Arapshian, Alice
    Kouides, Peter
    James, Paula
    Connell, Nathan T.
    Flood, Veronica H.
    Mustafa, Reem A.
    [J]. HAEMOPHILIA, 2022, 28 (03) : 373 - 387
  • [3] Long-term prophylaxis in von Willebrand disease
    Berntorp, E
    Petrini, P
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 : S23 - S26
  • [4] Efficacy and safety of a von Willebrand factor concentrate with a low FVIII content in children with von Willebrand disease (vwd)
    Borel-Derlon, A.
    Aronis, S.
    Platokouki, H.
    Maes, P.
    Chatelanaz, C.
    Bridey, F.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 530 - 530
  • [5] Management of joint replacement surgery with a von Willebrand factor product with a low FVIII content in von Willebrand disease patients
    Borel-Derlon, A.
    Federici, A. B.
    Goudemand, J.
    Roussel-Robert, V
    Chatelanaz, C.
    Henriet, C.
    Bridey, F.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 668 - 668
  • [6] Individually tailored prophylaxis in Type 3 von Willebrand Disease patients: efficacy and safety of a von Willebrand Factor concentrate with a low factor VIII content
    Gouider, E.
    Peerlinck, K.
    Hermans, C.
    Gadisseur, A.
    Klukowska, A.
    Knuchel, N.
    Stevens, W.
    Matysiak, M.
    Meddeb, B.
    Henriet, C.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 945 - 945
  • [7] Use of the von Willebrand factor concentrate with low factor VIII content to manage patients with inherited von Willebrand disease requiring surgical or secondary long-term prophylaxis: An expert opinion paper from an Italian panel
    Castaman, Giancarlo
    Borchiellini, Alessandra
    Coppola, Antonio
    Cultrera, Dorina
    Marino, Renato
    Federici, Augusto B.
    Giuffrida, Anna Chiara
    Marchesini, Emanuela
    Molinari, Angelo Claudio
    Maria, Siboni Simona
    Zanon, Ezio
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 109 (02) : 121 - 128
  • [8] Management of dental extractions by a von Willebrand factor product VWF with low FVIII content (Wilfactin®) in von Willebrand disease patients
    Borel-Derlon, A.
    Federici, A.
    Chatelanaz, C.
    Bridey, F.
    [J]. HAEMOPHILIA, 2008, 14 : 36 - 36
  • [9] Cost model of long-term prophylaxis with von Willebrand factor concentrate
    Palomero, A.
    Calvo, J. M.
    [J]. HAEMOPHILIA, 2024, 30 : 132 - 133
  • [10] Long term prophylaxis in children with type 3 Von Willebrand disease - To do or not to do?
    Aytac, Selin
    Coskun, Cagri
    Aksu, Tekin
    [J]. HAEMOPHILIA, 2020, 26 : 68 - 68
12345